|
|
Volumn 168, Issue 7, 2011, Pages 751-752
|
|
Monitoring ketamine treatment response in a depressed patient via peripheral mammalian target of rapamycin activation
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
ATYPICAL ANTIPSYCHOTIC AGENT;
BENZODIAZEPINE;
CITALOPRAM;
CLOMIPRAMINE;
ESCITALOPRAM;
KETAMINE;
MAMMALIAN TARGET OF RAPAMYCIN;
MOCLOBEMIDE;
VENLAFAXINE;
ADULT;
BECK DEPRESSION INVENTORY;
BRIEF PSYCHIATRIC RATING SCALE;
CASE REPORT;
DRUG EFFICACY;
DRUG MEGADOSE;
DRUG MONITORING;
FEMALE;
HUMAN;
LETTER;
MAJOR DEPRESSION;
MONOAMINERGIC SYSTEM;
MONTGOMERY ASBERG DEPRESSION RATING SCALE;
NERVE CELL PLASTICITY;
NEUROTRANSMISSION;
PRIORITY JOURNAL;
PROTEIN PHOSPHORYLATION;
TREATMENT RESPONSE;
WESTERN BLOTTING;
ADOLESCENT;
ANIMALS;
ANTIDEPRESSIVE AGENTS;
DEPRESSIVE DISORDER, MAJOR;
DRUG RESISTANCE;
FEMALE;
HUMANS;
KETAMINE;
MIDDLE AGED;
PHOSPHORYLATION;
RATS;
RECEPTORS, N-METHYL-D-ASPARTATE;
SIROLIMUS;
TREATMENT OUTCOME;
|
|
EID: 79960544100
PISSN: 0002953X
EISSN: 15357228
Source Type: Journal
DOI: 10.1176/appi.ajp.2011.11010128 Document Type: Letter |
|
Times cited : (56)
|
|
References (4)
|
